Edition:
India

Owens & Minor Inc (OMI.N)

OMI.N on New York Stock Exchange

15.11USD
1:32am IST
Change (% chg)

$-0.34 (-2.20%)
Prev Close
$15.45
Open
$15.47
Day's High
$15.52
Day's Low
$14.97
Volume
190,520
Avg. Vol
425,085
52-wk High
$34.92
52-wk Low
$14.28

Select another date:

Tue, Mar 27 2018

BRIEF-Owens & Minor CEO P. Cody Phipps' Total Pay For 2017 Was $6.7 Mln Vs $6.3 Mln In 2016 - SEC Filing

* OWENS & MINOR CEO P. CODY PHIPPS' TOTAL COMPENSATION FOR 2017 WAS $6.7 MILLION VERSUS $6.3 MILLION IN 2016 - SEC FILING Source text: (https://bit.ly/2DXIvZj) Further company coverage:

BRIEF-Owens & Minor Names Dominion Energy Executive To Its Board

* OWENS & MINOR NAMES DOMINION ENERGY EXECUTIVE, MARK MCGETTRICK, TO ITS BOARD OF DIRECTORS

BRIEF-Owens & Minor Q4 Revenue $2.39 Bln Versus $2.37 Bln

* OWENS & MINOR REPORTS 4TH QUARTER & FULL-YEAR 2017 FINANCIAL RESULTS

BRIEF-Owens & Minor Sees FY'17 EPS Of $1.17 To $1.20

* ‍OWENS & MINOR REVISES EXPECTATIONS FOR 2017 EARNINGS AND REVENUES​

BRIEF-Owens & Minor Announces Updates On Pending Acquisition Of Halyard Health's S&IP Business

* OWENS & MINOR ANNOUNCES UPDATES ON PENDING ACQUISITION OF HALYARD HEALTH’S S&IP BUSINESS

Fitch Downgrades Owens & Minor, Inc.'s IDR to 'BB+'; Outlook to Negative

(The following statement was released by the rating agency) NEW YORK, November 03 (Fitch) Fitch Ratings has downgraded the Long-Term Issuer Default Rating (IDR) of Owen & Minor, Inc. to 'BB+' from 'BBB-'. The Rating Outlook is revised to Negative from Stable. A full list of rating actions follows at the end of this release. The downgrade and Negative Outlook reflect OMI's shift toward a more acquisitive growth strategy, higher financial leverage, and the expectation of weaker revenues and margin

BRIEF-Halyard Health to sell S&IP business to Owens & Minor

* Halyard Health, Inc. announces sale of S&IP business to Owens & Minor, Inc. for $710 million

BRIEF-Owens & Minor to buy Halyard Health's surgical & infection prevention business for $710 mln

* Owens & Minor to acquire Halyard Health Inc's surgical & infection prevention (S&IP) business for $710 million in cash

BRIEF-Owens & Minor Q3 adjusted earnings per share $0.40

* Q3 earnings per share view $0.50 -- Thomson Reuters I/B/E/S

Select another date: